NASDAQ:HSIC

Henry Schein - HSIC Stock Forecast, Price & News

$76.45

-1.15 (-1.48%)

(As of 08/16/2022 12:00 AM ET)

Add

Compare

Today's Range: $75.99
▼
$77.75
50-Day Range: $73.17
▼
$83.49
52-Week Range: $70.25
▼
$92.68

Volume: 764,448 shs
Average Volume: 917,472 shs
Market Capitalization: $10.41 billion

P/E Ratio: 16.41
Dividend Yield: N/A
Price Target: $85.89

Henry Schein MarketRank™ Forecast

Analyst Rating: Hold
2.25 Rating Score
Upside/Downside: 12.3% Upside
$85.89 Price Target
Short Interest: Healthy
2.87% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.99
Upright™ Environmental Score
News Sentiment: 0.37
Based on 14 Articles This Week
Insider Trading: Selling Shares
$981,965 Sold Last Quarter
Proj. Earnings Growth: 6.60%
From $4.85 to $5.17 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.45 out of 5 stars

Medical Sector

230th out of 1,124 stocks

Medical & Hospital Equipment Industry

2nd out of 3 stocks

3.1

Analyst's Opinion

Consensus Rating
Henry Schein has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 3 buy ratings, 4 hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $85.89, Henry Schein has a forecasted upside of 12.3% from its current price of $76.45.
Amount of Analyst Coverage
Henry Schein has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.0

Short Interest

Percentage of Shares Shorted
2.87% of the float of Henry Schein has been sold short.
Short Interest Ratio / Days to Cover
Henry Schein has a short interest ratio ("days to cover") of 4.6.
Change versus previous month
Short interest in Henry Schein has recently decreased by 4.41%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Henry Schein does not currently pay a dividend.
Dividend Growth
Henry Schein does not have a long track record of dividend growth.

3.5

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Henry Schein has received a 40.81% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Wholesale of pharmaceuticals", "Management consulting for the health and wellbeing industry", and "Wholesale of diagnostic and treatment equipment" products. See details.
Environmental Sustainability
The Environmental Impact score for Henry Schein is -1.99.

2.4

News and Social Media Coverage

News Sentiment
Henry Schein has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 14 news articles for Henry Schein this week, compared to 5 articles on an average week.
Search Interest
4 people have searched for HSIC on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
MarketBeat Follows
Only 3 people have added Henry Schein to their MarketBeat watchlist in the last 30 days. This is a decrease of -57% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Henry Schein insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $981,965.00 in company stock.
Percentage Held by Insiders
Only 1.00% of the stock of Henry Schein is held by insiders.
Percentage Held by Institutions
94.30% of the stock of Henry Schein is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Henry Schein are expected to grow by 6.60% in the coming year, from $4.85 to $5.17 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Henry Schein is 16.41, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 129.97.
Price to Earnings Ratio vs. Sector
The P/E ratio of Henry Schein is 16.41, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 123.43.
Price to Earnings Growth Ratio
Henry Schein has a PEG Ratio of 2.09. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Henry Schein has a P/B Ratio of 2.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Henry Schein (NASDAQ:HSIC) Stock

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on HSIC shares. The Goldman Sachs Group lowered Henry Schein from a "buy" rating to a "neutral" rating and decreased their target price for the company from $93.00 to $85.00 in a research report on Thursday, July 21st. Evercore ISI reduced their price target on Henry Schein to $83.00 in a research report on Tuesday, August 9th. William Blair reissued a "market perform" rating on shares of Henry Schein in a research report on Tuesday, May 3rd. StockNews.com lowered Henry Schein from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, July 19th. Finally, Stifel Nicolaus reduced their price target on Henry Schein from $90.00 to $80.00 in a research report on Friday, June 17th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $85.89.

Henry Schein Stock Down 1.5 %

Shares of HSIC opened at $76.45 on Wednesday. Henry Schein has a 52 week low of $70.25 and a 52 week high of $92.68. The company has a quick ratio of 0.95, a current ratio of 1.83 and a debt-to-equity ratio of 0.18. The company has a market capitalization of $10.41 billion, a price-to-earnings ratio of 16.41, a PEG ratio of 2.09 and a beta of 0.75. The stock's 50-day moving average price is $76.81 and its 200-day moving average price is $82.13.

Henry Schein (NASDAQ:HSIC - Get Rating) last issued its earnings results on Tuesday, August 2nd. The company reported $1.16 EPS for the quarter, hitting analysts' consensus estimates of $1.16. Henry Schein had a return on equity of 15.56% and a net margin of 5.11%. The firm had revenue of $3.03 billion for the quarter, compared to the consensus estimate of $3.12 billion. During the same quarter in the prior year, the business earned $1.11 earnings per share. The company's revenue was up 2.1% compared to the same quarter last year. On average, sell-side analysts predict that Henry Schein will post 4.85 EPS for the current year.

Insider Buying and Selling

In related news, EVP Gerald A. Benjamin sold 11,489 shares of the company's stock in a transaction dated Thursday, May 26th. The stock was sold at an average price of $85.47, for a total value of $981,964.83. Following the completion of the transaction, the executive vice president now owns 95,616 shares of the company's stock, valued at approximately $8,172,299.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.00% of the stock is currently owned by insiders.

Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

HSIC Stock News Headlines

August 12, 2022 | marketwatch.com

Uptrend Call Working As Henry Schein Inc Stock Rises -0.6% (HSIC)

August 11, 2022 | finance.yahoo.com

Henry Schein Announces the Passing of Board Member E. Dianne Rekow

August 11, 2022 | americanbankingnews.com

Evercore ISI Trims Henry Schein (NASDAQ:HSIC) Target Price to $83.00

August 10, 2022 | americanbankingnews.com

UBS Group Upgrades Henry Schein (NASDAQ:HSIC) to Neutral

August 8, 2022 | markets.businessinsider.com

Expert Ratings for Henry Schein

August 7, 2022 | americanbankingnews.com

Henry Schein (NASDAQ:HSIC) Price Target Cut to $90.00 by Analysts at Credit Suisse Group

August 7, 2022 | americanbankingnews.com

Research Analysts Issue Forecasts for Henry Schein, Inc.'s Q4 2022 Earnings (NASDAQ:HSIC)